We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+0.03%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$184M
AUM Growth
-$5.72M
Cap. Flow
-$3.3M
Cap. Flow %
-1.8%
Top 10 Hldgs %
49.88%
Holding
105
New
16
Increased
25
Reduced
26
Closed
9

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$1.54M
2
AMD icon
Advanced Micro Devices
AMD
+$1.11M
3
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$1.08M
4
BOXX icon
Alpha Architect 1-3 Month Box ETF
BOXX
+$773K
5
XNCR icon
Xencor
XNCR
+$712K

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$2.12M
2
ARGX icon
argenx
ARGX
+$1.81M
3
JNJ icon
Johnson & Johnson
JNJ
+$761K
4
VIR icon
Vir Biotechnology
VIR
+$642K
5
PANW icon
Palo Alto Networks
PANW
+$639K

Sector Composition

Rank Sector Weight
1 Healthcare 33.26%
2 Technology 15.1%
3 Communication Services 6.79%
4 Consumer Discretionary 3.39%
5 Financials 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VIR icon
101
CALL
Vir Biotechnology
VIR
$1.46B
– –
-50,100
Closed -$1.23M
VIR icon
102
PUT
Vir Biotechnology
VIR
$1.46B
– –
-34,500
Closed -$846K
WOLF icon
103
CALL
Wolfspeed
WOLF
$1.23B
– –
-2,000
Closed -$111K
1 2 3 4
5

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, DCF Advisers held 105 positions worth $184M, down 3% from $189M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

DCF Advisers's Q3 2023 filing shows 16 new, 25 increased, 26 reduced and 9 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 13,500 shares worth $986K. The largest sale was Amgen, an estimated $2.12M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

  • DCF Advisers's largest Q3 2023 buy was State Street SPDR S&P Biotech ETF: 13,500 shares worth $986K.
  • DCF Advisers added most to iShares Russell 2000 ETF in Q3 2023, an estimated $1.54M increase.
  • DCF Advisers's biggest Q3 2023 reduction was Amgen, cutting an estimated $2.12M.
  • DCF Advisers fully exited Palo Alto Networks in Q3 2023, selling an estimated $639K.
  • DCF Advisers's ten largest holdings make up 50% of its $184M portfolio in Q3 2023.
  • DCF Advisers opened 16 new positions and closed 9 in Q3 2023.
  • DCF Advisers's portfolio value fell 3% quarter-over-quarter to $184M.

Based on DCF Advisers's 13F filing for Q3 2023, filed 13 Nov 2023.